Company Filing History:
Years Active: 2019
Title: Samuel Henry Stemberg: Innovator in CRISPR Technology
Introduction
Samuel Henry Stemberg is a notable inventor based in New York, NY (US). He has made significant contributions to the field of genetic engineering, particularly through his work with CRISPR technology. His innovative approach has led to advancements that could have far-reaching implications in various scientific domains.
Latest Patents
Stemberg holds a patent for "Engineered cascade components and cascade complexes." This patent provides engineered Class 1 Type I CRISPR-Cas (Cascade) systems that comprise multi-protein effector complexes, nucleoprotein complexes comprising Type I CRISPR-Cas subunit proteins and nucleic acid guides, polynucleotides encoding Type I CRISPR-Cas subunit proteins, and guide polynucleotides. The patent also discloses methods for making and using these engineered Class 1 Type I CRISPR-Cas systems.
Career Highlights
Samuel Stemberg is currently associated with Caribou Biosciences, Inc., where he continues to push the boundaries of genetic research. His work is instrumental in developing innovative solutions that leverage CRISPR technology for various applications.
Collaborations
Stemberg collaborates with talented individuals in his field, including Peter Sean Cameron and Sanne Eveline Klompe. These partnerships enhance the research and development efforts at Caribou Biosciences, Inc.
Conclusion
Samuel Henry Stemberg is a pioneering inventor whose work in CRISPR technology is shaping the future of genetic engineering. His contributions are vital to advancing scientific knowledge and applications in this rapidly evolving field.